BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18567868)

  • 21. Familial autoimmune myasthenia gravis: report of four families.
    Evoli A; Batocchi AP; Zelano G; Uncini A; Palmisani MT; Tonali P
    J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):729-31. PubMed ID: 7608676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTPN22 C1858T polymorphism and human brucellosis.
    Bravo MJ; Colmenero JD; Queipo-Ortuño MI; Morata P; Orozco G; Martin J; Alonso A; Caballero A
    Scand J Infect Dis; 2009; 41(2):109-12. PubMed ID: 19107641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE; Gessner JE
    Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis.
    Giraud M; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Genes Immun; 2004 Jan; 5(1):80-3. PubMed ID: 14735155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 promoter polymorphisms in myasthenia gravis.
    Alseth EH; Nakkestad HL; Aarseth J; Gilhus NE; Skeie GO
    J Neuroimmunol; 2009 May; 210(1-2):63-6. PubMed ID: 19299022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetics of human autoimmune disease.
    Invernizzi P; Gershwin ME
    J Autoimmun; 2009; 33(3-4):290-9. PubMed ID: 19682858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of shared autoimmunity.
    Alarcón-Riquelme ME
    Autoimmunity; 2005 May; 38(3):205-8. PubMed ID: 16126508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis.
    Xiong X; Xiang M; Cheng X; Huang Y
    Med Sci Monit; 2015 Aug; 21():2567-71. PubMed ID: 26318187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
    Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
    Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetics of autoimmune diseases: a networked perspective.
    Baranzini SE
    Curr Opin Immunol; 2009 Dec; 21(6):596-605. PubMed ID: 19896815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed Death-1: from gene to protein in autoimmune human myasthenia gravis.
    Sakthivel P; Ramanujam R; Wang XB; Pirskanen R; Lefvert AK
    J Neuroimmunol; 2008 Jan; 193(1-2):149-55. PubMed ID: 18037500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population.
    Douroudis K; Prans E; Haller K; Nemvalts V; Rajasalu T; Tillmann V; Kisand K; Uibo R
    Tissue Antigens; 2008 Nov; 72(5):425-30. PubMed ID: 18764813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The etiology of autoimmune diseases: the case of myasthenia gravis.
    Bach JF
    Ann N Y Acad Sci; 2012 Dec; 1274():33-9. PubMed ID: 23252895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of autoimmune neuroinflammation.
    Olsson T; Jagodic M; Piehl F; Wallström E
    Curr Opin Immunol; 2006 Dec; 18(6):643-9. PubMed ID: 16973343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.
    Gu M; Kakoulidou M; Giscombe R; Pirskanen R; Lefvert AK; Klareskog L; Wang X
    Clin Immunol; 2008 Sep; 128(3):374-81. PubMed ID: 18595775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in genetic predisposition of myasthenia gravis.
    Zagoriti Z; Kambouris ME; Patrinos GP; Tzartos SJ; Poulas K
    Biomed Res Int; 2013; 2013():404053. PubMed ID: 24294607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C.
    Janer M; Cowland A; Picard J; Campbell D; Pontarotti P; Newsom-Davis J; Bunce M; Welsh K; Demaine A; Wilson AG; Willcox N
    Hum Immunol; 1999 Sep; 60(9):909-17. PubMed ID: 10527401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.